Role of active and latent transforming growth factor β in bone formation

Journal of Cellular Biochemistry

Volumn 55, Issue 3, 1994, Pages 350-357

  Bonewald, L F ^a   Dallas, S L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

bone formation; mineralization; osteoblasts; osteoclasts; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

MINERALIZATION; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; REVIEW;

ANIMAL; BONE DENSITY; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; HUMAN; PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0028362420     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.240550312     Document Type: Article

References (59)

1. Expression of human bone morphogenetic proteins‐2 or ‐4 in murine mesenchymal progenitor C3H10T 1/2 cells induces differentiation into distinct mesenchymal cell lineages
2. TGFβ and wound healing
3. An activated form of transforming growth factor β is produced by co‐cultures of endothelial cells and pericytes
4. Effects of transforming growth factor β and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells
5. Transforming growth factor beta in leishmanial infection: A parasite escape mechanism
6. TGFβ1 induces bone closure of skull defects
7. Role of transforming growth factor‐beta in bone remodeling
8. Latent forms of transforming growth factor‐beta (TGFβ) derived from bone cultures. Identification of a naturally occurring 100‐kDa complex with similarity to recombinant later TGFβ
9. 3 on differentiation of a human osteosarcoma (MG‐63)
10. Transforming growth factorbeta in disease: The dark side of tissue repair
11. Natural inhibitor of TGF‐beta protects against scarring in experimental kidney disease
12. Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein‐DNA interactions at promoter regulatory elements
13. Evolutionary origins of the transforming growth factor‐β gene family
14. Current concepts review: Transforming growth factor‐β and remodeling of bone
15. Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture
16. Proliferating fetal rat calvarial cells produce distinctly different forms of latent transforming growth factor beta (TGFβ) compared to mineralizing cells
17. Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast‐like cell lines: Production of a latent complex lacking the latent TGFβ‐binding protein (LTBP)
18. Basic growth factor β in endothelial cells: Regulation of plasminogen activator activity
19. Type I transforming growth factor beta: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells
20. Human transforming growth factor‐β3: Recombinant expression, purification, and biological activities in comparison with transforming growth factors‐β1 and ‐β2
21. 3‐induced inhibition of bone nodule formation in long term cultures of fetal rat calvarial cells
22. Transforming growth factor‐beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum‐derived cells
23. Experimental allergic encephalomyelitis: Neutralizing antibody to TGFβ1 enhance the clinical severity of the disease
24. TGFβ1 binding protein: A compotent of the large latent complex of TGFβ1, with multiple repeat sequences
25. Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: Regulation by transforming growth factor beta and serum factors
26. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death
27. Expression of human bone‐related proteins in the hematopoietic micro‐environment
28. Betaglycan presents ligand to the TGFβ signaling receptor
29. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin
30. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice
31. Complementary DNA cloning of the murine transforming growth factor‐β3 (TGFβ3) precursor and the comparative expression of TGFβ3 and TGFβ1 messenger RNA in murine embryos and adult tissues
32. Latent high molecular weight complex of transforming growth factor beta
33. TGFβ stimulation and inhibition of cell proliferation: New mechanistic insights
34. Transcriptional regulation of osteocalcin production by transforming growth factor‐β in rat osteoblast‐like cells
35. In vivo stimulation of bone formation by transforming growth factor‐beta
36. Type‐β transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast‐like cells
37. 2 macroglobulin
38. Activation of the bone derived latent TGF beta complex by isolated osteoclasts
39. Osteoclast synthesis, secretion, and activation of latent transforming growth factor‐β
40. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal osteoblast cultures
41. 3, PTH and dexamethasone on ecto‐NTP pyrophosphatase activity of human osteoblast‐like cells in vitro
42. Transforming growth factor β increases ecto‐nucleoside triphosphate pyrophosphatase activity of human bone‐derived cells
43. Chemotactic response of osteoblast‐like cells to transforming growth factor β
44. Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones
45. Isolation and sequence of the vitamin K–dependent protein from human bone
46. Glucocorticoid regulation of transforming growth factor β activation in urogenital sinus mesenchymal cells
47. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor‐β1–like molecule by plasmin during co‐culture
48. The mechanism for the activation of latent TGF‐β during co‐culture of endothelial cells and smooth muscle cells: Cell‐type specific targeting of latent TGF‐β to smooth muscle cells
49. Thrombospondin causes activation of latent transforming growth factor‐β secreted by endothelial cells by a novel mechanism
50. Purification and characterization of two cartilage‐inducing factors from bovine demineralized bone
51. Targeted disruption of the mouse transforming growth factor‐β1 gene results in multifocal inflammatory disease
52. Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues
53. γ‐interfern–induced activation of latent transforming growth factor β by human monocytes
54. Latent transforming growth factor‐beta from human platelets. A high molecular weight complex containing precursor sequences
55. 3
56. Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells